Barclays raised the firm’s price target on Kodiak Sciences (KOD) to $4 from $3 and keeps an Underweight rating on the shares. The firm says the company’s Q3 highlighted recent progress and provided update across key pipeline programs.
Barclays raised the firm’s price target on Kodiak Sciences (KOD) to $4 from $3 and keeps an Underweight rating on the shares. The firm says the company’s Q3 highlighted recent progress and provided update across key pipeline programs.